Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Change in Receivables (2022 - 2025)

PAVmed has reported Change in Receivables over the past 4 years, most recently at $12000.0 for Q4 2025.

  • Quarterly results put Change in Receivables at $12000.0 for Q4 2025, up 500.0% from a year ago — trailing twelve months through Dec 2025 was -$3000.0 (down 101.61% YoY), and the annual figure for FY2025 was -$3000.0, up 93.02%.
  • Change in Receivables for Q4 2025 was $12000.0 at PAVmed, up from -$7000.0 in the prior quarter.
  • Over the last five years, Change in Receivables for PAVM hit a ceiling of $152000.0 in Q2 2024 and a floor of -$111000.0 in Q1 2022.
  • Median Change in Receivables over the past 4 years was $4000.0 (2024), compared with a mean of $1285.7.
  • Biggest five-year swings in Change in Receivables: soared 985.71% in 2024 and later tumbled 233.33% in 2025.
  • PAVmed's Change in Receivables stood at -$14000.0 in 2022, then soared by 285.71% to $26000.0 in 2023, then crashed by 92.31% to $2000.0 in 2024, then surged by 500.0% to $12000.0 in 2025.
  • The last three reported values for Change in Receivables were $12000.0 (Q4 2025), -$7000.0 (Q2 2025), and -$8000.0 (Q1 2025) per Business Quant data.